Brind.

OCS appointed Snehal Shah as President of R&D on August 12, 2025.

1 report, 1 independent Updated Aug 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

OCSSnehal Shah

Keep exploring

The entities involved

OCS
company based in Latvia
- OCS is anticipated to become a new revenue stream for the company, building on its partnership with Nvidia.Mon 15:37
- Summit 2026 is taking place in Las Vegas, Nevada, with OCS sponsoring clinical trials.Sun 22:04

Coverage

Newest first; wire copies grouped

Aug 12GlobeNewswireOculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”),